Bionano Genomics, Inc.
Customers
3
0 disclosed, 1 federal agency
Suppliers
0
None disclosed
Largest customer
—
No % disclosed
Named-customer revenue
—
No estimate available
Federal obligations
$1.1M
FY2026 · USAspending.gov
Latest period
Dec 31, 2020
10-Q filed 2021-05-13
Customers 2
Companies BNGO discloses as major customers, as a share of BNGO revenue. 0 active, 2 lapsed.
| Company | % of BNGO revenue | Est. revenue | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| DGX QUEST DIAGNOSTICS INC |
Named | — | FY 2020-12-31 | — | Lapsed Last seen 2020-12-31 |
10-Q 2021-05-13 |
As of December 31, 2020, Illumina, and Quest Diagnostics represented 17.3%, and 10.1%, respectively, of the Company’s total accounts receivable balance. | ||||||
| ILMN ILLUMINA, INC. |
Named | — | FY 2020-12-31 | — | Lapsed Last seen 2020-12-31 |
10-Q 2021-05-13 |
As of December 31, 2020, Illumina, and Quest Diagnostics represented 17.3%, and 10.1%, respectively, of the Company’s total accounts receivable balance. | ||||||
Federal contracts 1
Agencies that awarded contracts to this company, from USAspending.gov. Dollars are obligated amounts as reported, not estimates; $1.1M in the latest fiscal year shown per agency.
| Agency | Obligated | Fiscal year | Awards | Trend | Largest award |
|---|---|---|---|---|---|
| Department of Defense
Defense Health Agency |
$1.1M | FY 2026 | 5 | $1.1M → $1.1M | HT942726FE092 |
MYBAITS CUSTOM TARGET ENRICHMENT KITS | |||||
Unnamed major customers
Disclosed without names in the fiscal year ending 2024-12-31. Identities are not inferred.
Alerts are coming
Get an email when BNGO's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.